A proactive, interdisciplinary approach is essential to effectively manage the evolving challenges associated with 505(b)(2) medications. Implementing structured tools, including a crosswalk comparison tool, directory, and prioritization matrix, provided a systematic method to identify and monitor these products within a complex regulatory environment. Continued refinement will be necessary as CMS and Food and Drug Administration policies evolve, but this model offers a framework that may be adapted to different care settings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Chloe Matsuda
Russell Findlay
Utah Department of Health
Erin R. Fox
American Journal of Health-System Pharmacy
Utah Department of Health
Building similarity graph...
Analyzing shared references across papers
Loading...
Matsuda et al. (Thu,) studied this question.
synapsesocial.com/papers/69ada885bc08abd80d5bb867 — DOI: https://doi.org/10.1093/ajhp/zxag063